JP Patent

JP2001504105A — Ｇｌｐ―１ペプチドの利用

Assigned to Novo Nordisk AS · Expires 2001-03-27 · 25y expired

What this patent protects

(57)【要約】 食欲の抑制又は飽食感の誘導のために末梢投与される薬物の調製において、GLP-1(1-45)、又はこの断片、又はこの類似体を利用することができる。

USPTO Abstract

(57)【要約】 食欲の抑制又は飽食感の誘導のために末梢投与される薬物の調製において、GLP-1(1-45)、又はこの断片、又はこの類似体を利用することができる。

Drugs covered by this patent

Patent Metadata

Patent number
JP2001504105A
Jurisdiction
JP
Classification
—
Expires
2001-03-27
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.